Inventor · disambiguated record
Efrat Ozeri-Galai
Also filed as: OZERI-GALAI EFRAT
1 granted patent·7 pending applications·0 citations·filing 2020–2024
14Inventor score
Files withSPLISENSE LTD5YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD2YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIV OF JERUSALEM1
Top patents by PatentIndex Score
8 records- 0171US12351803B2Restoration of the CFTR function by splicing modulationYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2024·Granted Jul 8, 2025·0 cites·13 claims
- 0260US2024409930A1Muc5b-targeted antisense oligonucleotides and related methods for modulating mucin expressionSPLISENSE LTD·Filed 2024·Application pending·0 cites
- 0354US2025297247A1Muc5ac-targeted antisense oligonucleotides and related methods for modulating mucin expressionSPLISENSE LTD·Filed 2022·Application pending·0 cites
- 0448US2022213479A1Restoration of the cftr function by splicing modulationYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2020·Application pending·0 cites
- 0542US2022220486A1Combination treatments for cystic fibrosis characterized by a 3849 + 10kb c-to-t cftr mutationYISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIV OF JERUSALEM·Filed 2022·Application pending·0 cites
- 0635US2022040219A1Compositions and methods for treating cystic fibrosisSPLISENSE LTD·Filed 2020·Application pending·0 cites
- 0731US2023142669A1Compositions and methods for treating cystic fibrosisSPLISENSE LTD·Filed 2021·Application pending·0 cites
- 0827US2022064647A1Compositions and methods for treating cystic fibrosisSPLISENSE LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Efrat Ozeri-Galai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →